10q22.3q23.3 microdeletion syndrome

10q22.3q23.3 microdeletion syndrome (also known as 10q22.3-q23.3 deletion syndrome) is a rare chromosomal disorder caused by a submicroscopic deletion on the long arm of chromosome 10, spanning the 10q22.3 to 10q23.3 region. This deletion typically arises de novo, meaning it occurs as a new genetic event rather than being inherited from a parent. The deleted region encompasses several genes, and the loss of these genes leads to a recognizable pattern of developmental and physical abnormalities. The syndrome primarily affects the neurological system, musculoskeletal system, and craniofacial structures. Key clinical features include intellectual disability of variable severity, global developmental delay (particularly speech and language delay), and distinctive facial features such as a broad or prominent forehead, hypertelorism (widely spaced eyes), a flat nasal bridge, thin upper lip, and low-set or posteriorly rotated ears. Many affected individuals also exhibit hypotonia (low muscle tone), behavioral difficulties including features of autism spectrum disorder or attention deficit hyperactivity disorder, and feeding difficulties in infancy. Some patients may present with cardiac anomalies, urogenital malformations, or skeletal abnormalities. There is currently no cure or targeted therapy for 10q22.3q23.3 microdeletion syndrome. Management is supportive and symptom-based, involving early intervention programs, speech and language therapy, occupational therapy, physical therapy, and special educational support. Regular monitoring by a multidisciplinary team including developmental pediatricians, neurologists, cardiologists, and other specialists is recommended to address the various medical and developmental needs of affected individuals. Genetic counseling is advised for families to understand recurrence risks and the nature of the condition.

Common questions about 10q22.3q23.3 microdeletion syndrome